KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) Depreciation Expense (2016 - 2025)

Historic Depreciation Expense for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $6.9 million.

  • Medpace Holdings' Depreciation Expense fell 320.5% to $6.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.2 million, marking a year-over-year decrease of 218.64%. This contributed to the annual value of $27.2 million for FY2025, which is 218.64% down from last year.
  • Per Medpace Holdings' latest filing, its Depreciation Expense stood at $6.9 million for Q4 2025, which was down 320.5% from $6.8 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Depreciation Expense peaked at $7.2 million during Q3 2024, and registered a low of $3.8 million during Q1 2021.
  • For the 5-year period, Medpace Holdings' Depreciation Expense averaged around $5.7 million, with its median value being $6.1 million (2023).
  • As far as peak fluctuations go, Medpace Holdings' Depreciation Expense skyrocketed by 5540.15% in 2021, and later crashed by 481.98% in 2025.
  • Medpace Holdings' Depreciation Expense (Quarter) stood at $4.2 million in 2021, then grew by 21.17% to $5.1 million in 2022, then increased by 26.62% to $6.4 million in 2023, then grew by 11.26% to $7.1 million in 2024, then dropped by 3.21% to $6.9 million in 2025.
  • Its Depreciation Expense was $6.9 million in Q4 2025, compared to $6.8 million in Q3 2025 and $6.8 million in Q2 2025.